Advertisement

Ads Placeholder
Loading...

Celcuity Inc.

CELCNASDAQ
Healthcare
Biotechnology
$112.63
$-0.30(-0.27%)
U.S. Market opens in 27h 57m

Celcuity Inc. (CELC) Stock Overview

Explore Celcuity Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.4B
P/E Ratio-33.42
EPS (TTM)$-3.79
ROE-2.03%
Fundamental Analysis

AI Price Forecasts

1 Month$108.23
3 Months$73.00
1 Year Target$55.78

CELC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Celcuity Inc. (CELC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $55.78.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -33.42 and a market capitalization of 5.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.27%
5-Day Change
-0.24%
1-Month Change
4.87%
3-Month Change
12.01%
6-Month Change
122.99%
Year-to-Date (YTD) Change
12.01%
1-Year Change
1172.66%
3-Year Change
1021.81%
5-Year Change
690.39%
All-Time (Max) Change
688.17%

Contact Information

763 392 0767
16305–36th Avenue North, Minneapolis, MN, 55446

Company Facts

870 Employees
IPO DateSep 20, 2017
CountryUS
Actively Trading

Frequently Asked Questions